Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
The trial team is the right source for information about screening, visits, study medication, and participant responsibilities
The WW behavioral system is the most battle-tested weight-loss methodology in existence
Researchers have observed the drugs impact on diseases other than diabetes and obesity in clinical trials and among people taking the medications in real-world settings
Iepsen EW, Lundgren JR, Hartmann B, et al
placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
Furthermore, at the intestinal level, TCDCA-mediated activation of FXR leads to impaired nutrient-sensing mechanisms that regulate glucose homeostasis 273
